2023
OUTCOMES WITH CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTICVALVE REPLACEMENT: AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Al-Abdouh A, Mhanna M, Jabri A, Alhuneafat L, Zaalouk M, Ghanem F, Altibi A, Dewaswala N, Bhopalwala H, Barbarawi M, Kundu A, Elgendy I. OUTCOMES WITH CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTICVALVE REPLACEMENT: AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Journal Of The American College Of Cardiology 2023, 81: 820. DOI: 10.1016/s0735-1097(23)01264-0.Peer-Reviewed Original ResearchUpdate meta-analysisRandomized controlled trials
2019
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis
Masri A, Altibi A, Erqou S, Zmaili M, Saleh A, Al-Adham R, Ayoub K, Baghal M, Alkukhun L, Barakat A, Jain S, Saba S, Adelstein E. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis. JACC Clinical Electrophysiology 2019, 5: 152-161. PMID: 30784684, PMCID: PMC6383782, DOI: 10.1016/j.jacep.2018.11.011.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsWearable cardioverter-defibrillator therapyWearable cardioverter-defibrillatorVEST trialSudden cardiac deathDerSimonian and Laird methodCardiac deathMonths of follow-upPrevention of sudden cardiac deathA systematic reviewPrimary preventionOutcomes of patientsCardioverter-defibrillator therapyLaird methodObservational studyMeta-analysisGoogle ScholarIschemic cardiomyopathyMedical therapyFollow-upCardioverter-defibrillatorPreventionTherapyVestPersons
2016
Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials
Morra M, Elgebaly A, Elmaraezy A, Khalil A, Altibi A, Vu T, Mostafa M, Huy N, Hirayama K. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials. The Journal Of Headache And Pain 2016, 17: 63. PMID: 27377706, PMCID: PMC4932020, DOI: 10.1186/s10194-016-0651-8.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsTrigeminal neuralgiaBTX-AMeta-analysisSafety of BTX-AEfficacy of botulinum toxin type AMeta-analysis of randomized controlled trialsControlled trialsSystematic reviewRecurrent pain attacksTreatment of TNPublished randomized controlled trialsNo significant heterogeneityBTX-A groupBotulinum toxin type ABotulinum toxin A therapyPain attacksTN patientsToxin type AA therapyClinical outcomesTreatment optionsTherapeutic efficacyQuality of lifeProportion of respondents